In vivo assessment of human vaginal oxygen and carbon dioxide levels during and post menses

Journal of Applied Physiology

Volumn 99, Issue 4, 2005, Pages 1582-1591

  Hill, Donna R ^a   Brunner, Marianne E ^a   Schmitz, Deborah C ^a   Davis, Catherine C ^a   Flood, Janine A ^a   Schlievert, Patrick M ^b   Wang Weigand, Sherry Z ^a   Osborn, Thomas W ^a  

^a PROCTER AND GAMBLE COMPANY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Gaseous changes; Menstruation; Staphylococcus aureus

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CARBON DIOXIDE BLOOD LEVEL; DESQUAMATION; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; MENSTRUATION; OXYGEN BLOOD LEVEL; OXYGENATION; PRIORITY JOURNAL; RISK ASSESSMENT; STAPHYLOCOCCUS AUREUS; TAMPON; TOXIC SHOCK SYNDROME; VAGINA EPITHELIUM;

ADULT; CARBON DIOXIDE; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MENSTRUAL HYGIENE PRODUCTS; MENSTRUATION; OXYGEN; PARTIAL PRESSURE; POLYMERASE CHAIN REACTION; STAPHYLOCOCCAL INFECTIONS; VAGINA;

EID: 29544441503     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01422.2004     Document Type: Article

References (44)

1. Beller FK and Schweppe KW. Review on the biology of menstrual blood. In: The Biology of the Fluids of the Female Genital Tract, edited by Beller FK and Schumacker GFB. North-Holland, NY: Elseiver, 1979.
2. Bergdoll MS. Toxic shock syndrome. J Venom Anim Toxins 3: 6-21, 1997.
3. Berkley SF, Hightower AW, Broome CV, and Reingold AL. The relationship of tampon characteristics to menstrual toxic shock syndrome. J Am Med Assoc 258: 917-920, 1987.
4. Bonventre PF, Linnemann C, Weckback LS, Staneck JL, Buncher R, Vigdorth E, Ritz H, Archer D, and Smith B. Antibody responses to toxic-shock-syndrome (TSS) toxin by patients with TSS and by healthy staphylococcal carriers. J Infect Dis 150: 662-666, 1984.
5. Bonventre PF, Thompson MR, Adinolfi LE, Gillis ZA, and Parsonnet J. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun 56: 135-141, 1988.
6. Brackstad OG, Assbakk K, and Maeland JA. Detection of Staphylococcus aureus by polymerase chain reaction amplification of the nuc gene. J Clin Microbiol 62: 1654-1660, 1992.
7. Brown WJ. Variations in the vaginal bacterial flora: a preliminary report. Ann Intern Med 96: 931-934, 1982.
8. Casewell MW and Hill RL. The carrier state: methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 18m Suppl A: 1-12, 1986.
9. Chapin K and Musgnug M. Evaluation of three rapid methods for the direct identification of Staphylococcus aureus from positive blood cultures. J Clin Microbiol 41: 4224-4327, 2003.
10. Chow AW, Bartlett KH, Percival-Smith R, and Morrison BJ. Vaginal colonization with Staphylococcus aureus, positive for toxic-shock marker protein, and Escherichia coli in healthy women. J Infect Dis 150: 80-84, 1984.
11. Czerwinski BS. Variation in feminine hygiene practices as a function of age. J Obstet Gynecol Neonatal Nurs 29: 625-633, 2000.
12. Davis CC, Kremer MJ, Schlievert PM, and Squier CA. Penetration of toxic shock syndrome toxin-1 across porcine vaginal mucosa ex vivo: permeability characteristics, toxin distribution and tissue damage. Am J Obstet Gynecol 189: 1785-1791, 2003.
13. Davis JP, Chesney PJ, Wand PJ, and LaVenture M. Toxic-shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N Engl J Med 303: 1429-1435, 1980.
14. Dickgiesser N, Brombacher A, and Wiest W. Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears. Geburtshilfe Frauenheilkd 47: 104-106, 1987.
15. Korn AP, Hessol NA, Padian NS, Bolan GA, Donegan E, Landers DV, and Schacter J. Risk factors for plasma cell endometritis among women with cervical Neisseria gonorrhoeae, cervical Chlamydia trachomatis, or bacterial vaginosis. Am J Obstet Gynecol 178: 987-990, 1998.
16. Lanes SF and Rothman KJ. Tampon absorbency, composition and oxygen content and risk of toxic shock syndrome. J Clin Epidemiol 43: 1379-1385, 1990.
17. Lansdell LW, Taplin D, and Aldrich TE. Recovery of Staphylococcus aureus from multiple body sites in menstruating women. J Clin Microbiol 20: 307-310, 1984.
18. Lee-Wong AC and Downs SA. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus. J Clin Microbiol 27: 2482-2487, 1989.
19. Linnemann CCJ, Staneck JL, Hornstein S, Barden TP, Rauh JL, Boneventre PF, Buncher R, and Benting A. The epidemiology of genital colonization with Staphylococcus aureus. Ann Intern Med 96: 940-944, 1982.
20. Lowy FD. Staphylococcus aureus infections. N Engl J Med 339: 520-532, 1998.
21. Magid MO and Geiger J. The intravaginal tampon in menstrual hygiene: a clinical study. Med Record 155: 316-318, 1942.
22. Mayer KH and Anderson DJ. Heterosexual HIV transmission. Infect Agents Dis 4: 273-284, 1995.
23. Morgan C, Newell SJ, Ducker DA, Hodgkinson J, White DK, Morley CJ, and Church JM. Continuous neonatal blood gas monitoring using a multiparameter intra-arterial sensor. Arch Dis Child Fetal Neonatal Ed 80: F93-F98, 1999.
24. Nelson E and Jordan M. Sensitive export: seeking new markets for tampons, P&G faces cultural barriers. The Wall Street Journal December 8, A1, 2000.
25. Onderdonk AB, Zamarchi GR, Rodriguez ML, Hirsch ML, Munoz A, and Kass EH. Quantitative assessment of vaginal microflora during use of tampons of various compositions. Appl Environ Microbiol 53: 2774-2778, 1987.
26. Osterholm MT, Davis JP, Gibson RW, Mandel JS, Wintermeyer LA, Helms CM, Forang JC, Rondeau J, Vergeront JM, and the Investigation Team. Tri-state toxic-shock syndrome study. I. Epidemiologic findings. J Infect Dis 145: 431-440, 1982.
27. Reingold AL, Broome VC, Gaventa S, and Hightower AW. Risk factors for menstrual toxic shock syndrome: results of a multistate case-control study. Rev Infect Dis II: S35-S42, 1989.
28. Sarafian SK and Morse SA. Environmental factors affecting toxic shock syndrome toxin-1 (TSST-1) synthesis. J Med Microbiol 24: 75-81, 1987.
29. Schlech WF, Shands KN, Reingold AL, Dan BB, Schmid GP, Hargrett NT, Hightower A, Herwaldt LA, Neill MA, Band JD, and Bennett JV. Risk factors for development of toxic shock syndrome. JAMA 248: 835-839, 1982.
30. Schlievert PM, Blomster DA, and Kelly JA. Toxic shock syndrome Staphylococcus aureus: effect of tampons on toxics shock syndrome toxin-1 production. Obstet Gynecol 64: 666-670, 1985.
31. Schroder E, Kunstmann G, Hasbach H, and Pulverer G. Prevalence of serum antibodies to toxic-shock syndrome-toxin-1 and to staphylococcal enterotoxins A, B, and C in West Germany. Zentralbl Bakteriol A270: 110-114, 1988.
32. Shands KN, Schmid GP, Dan BB, Blum D, Guidotti RJ, Hagrett NT, Anderson RL, Hill DL, Broome CV, Band JD, and Fraser DW. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med 303: 1436-1442, 1980.
33. Shaw ST and Roche PL. Menstruation, In: Oxford Reviews of Reproductive Biology, edited by Finn CA. Oxford: Clarendon, 1980.
34. Shehin SE, Jones MB, Hochwalt AE, Sarbaugh FC, and Nunn S. Clinical safety in-use of a new tampon design. Infect Dis Obstet Gynecol 11: 89-100, 2003.
35. Smith CB, Noble V, Bensch R, Ahlin PA, Jacobson JA, and Latham RH. Bacterial flora of the vagina during the menstrual cycle: findings in users of tampons, napkins, and sea sponges. Ann Intern Med 96: 948-951, 1982.
36. Szaflarski NL. Emerging technology in critical care: continuous intraarterial blood gas monitoring. Am J Crit Care 5: 55-65, 1996.
37. 2+ limitation on toxic shock syndrome toxin-1 production by Staphylococcus aureus grown in defined continuous culture. J Gen Microbiol 134: 719-723, 1988.
38. Todd JK, Kapral FA, Fishaut M, and Welch TR. Toxic shock syndrome associated with phage group 1 staphylococci. Lancet 2: 1116-1118, 1978.
39. Veeh RH, Shirtliff ME, Petik JR, Flood JA, Davis CC, Seymour JL, Hansmann MA, Kerr KM, Pasmore ME, and Costeron JW. Detection of Staphylococcus aureus biofilm on tampons and menses components. J Infect Dis 188: 519-530, 2003.
40. Vergeront JM, Stolz SJ, Crass BA, Nelson DB, Davis JP, and Bergdoll MS. Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis 148: 692-698, 1983.
41. Wagner G and Ottesen B. Vaginal physiology during menstruation. Ann Intern Med 96: 921-923, 1982.
42. Wagner G, Bohr L, Wagner P, and Petersen LN. Tampon-induced changes in vaginal oxygen and carbon dioxide tensions. Am J Obstet Gynecol 148: 147-150, 1984.
43. Wong AC and Bergdoll MS. Effect of environmental conditions on production of toxic shock syndrome toxin 1 by Staphylococcus aureus. Infect Immun 58: 1026-1029, 1990.
44. Yarwood JM and Schlievert PM. Oxygen and carbon dioxide: regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8. J Clin Microbiol 38: 1797-1803, 2000.